Stocks Health care TRUP
NASDAQ · Health careTrupanion, Inc. (TRUP)
Trupanion, Inc. brought in $1.6B of revenue over the twelve months to September 30, 2026, up 11.4% from a year earlier. Net income was $26.6M, a net margin of 1.7%. Operating cash flow minus capital spending left $75.4M of free cash flow in fiscal 2025. At September 30, 2026 it held $170.4M in cash against $104.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Trupanion, Inc.
- Net worth
- Trupanion, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $399.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.4B (+11.9% year on year), with net income of $19.4M. Over the 12 months to September 30, 2026: revenue $1.6B, net income $26.6M.
- Cash flow
- In fiscal 2025 operations brought in $89.5M of cash; after $14.1M of capital spending, free cash flow was $75.4M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Trupanion, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Trupanion, Inc. does
Trupanion, Inc. is registered with the SEC under industry code SIC 6324 (Hospital & Medical Service Plans). Its shares trade on NASDAQ under the ticker TRUP.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4B | $19.4M | $0.45 | $75.4M |
| 2024 | $1.3B | -$9.6M | -$0.23 | $38.6M |
| 2023 | $1.1B | -$44.7M | -$1.08 | $358K |
| 2022 | $905.2M | -$44.7M | -$1.10 | -$25.1M |
| 2021 | $699M | -$35.5M | -$0.89 | -$4.9M |
| 2020 | $502M | -$5.8M | -$0.16 | $14.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where TRUP ranks in Health care
Latest SEC filings
What Trupanion, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 11% to $405.6M versus the same quarter last year; diluted EPS $0.21 versus $0.13.
- November 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 11% to $392.9M versus the same quarter last year; diluted EPS $0.16 versus $0.22.
- August 5, 2026
- June 15, 2026
- April 30, 2026
- April 30, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 12% to $384M versus the same quarter last year; diluted EPS $0.11 versus -$0.03.
- April 27, 2026
- April 27, 2026
What is TRUP worth? A DCF from its reported cash flow
Insider trades
What the people running Trupanion, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $379.3K worth of shares in the last 90 days and bought none on the open market. 48% of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 28, 2026 | Gallagher John RChief Operating Officer | Soldpre-planned (10b5-1) | 431 | $12.6K |
| October 9, 2026 | Tooth MargaretCEO, Director | Soldpre-planned (10b5-1) | 1,000 | $25.8K |
| September 28, 2026 | Gallagher John RChief Operating Officer | Soldpre-planned (10b5-1) | 431 | $9.9K |
| September 11, 2026 | Tooth MargaretCEO, Director | Soldpre-planned (10b5-1) | 1,000 | $25K |
| August 28, 2026 | Gallagher John RChief Operating Officer | Soldpre-planned (10b5-1) | 3,604 | $107K |
| August 26, 2026 | Qureshi FawwadChief Financial Officer | Sold | 6,111 | $183.4K |
| August 25, 2026 | Gallagher John RChief Operating Officer | Exercised options | 28 | - |
| August 25, 2026 | Gallagher John RChief Operating Officer | Shares withheld for tax | 6 | $191 |
Who owns TRUP
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Felix Holdings BV13G, passive | 9.89% | February 24, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 200 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 5,441,008 | -2,112 |
| Capital World Investors | 3,840,269 | +58,630 |
| Aflac Inc | 3,636,364 | 0 |
| Vanguard Portfolio Management LLC | 1,801,498 | +38,921 |
| Polar Capital Holdings Plc | 1,750,000 | +125,000 |
| Vanguard Capital Management LLC | 1,486,377 | +33,221 |
| State Street Corp | 1,365,662 | +48,219 |
| Fmr LLC | 1,040,565 | -314,001 |
| Morgan Stanley | 901,215 | +203,343 |
| Geode Capital Management, LLC | 875,839 | -2,231 |
| Greenlea Lane Capital Management, LLC | 776,490 | 0 |
| Bank of America Corp | 575,764 | -14,975 |
| Marshall Wace, Llp | 561,333 | -132,822 |
| Kopion Asset Management, LLC | 522,999 | +123,308 |
| Goldman Sachs Group Inc | 491,871 | +133,393 |
| Qube Research & Technologies Ltd | 406,217 | +59,911 |
| Clearbridge Investments, LLC | 395,906 | -45,566 |
| Dimensional Fund Advisors LP | 380,610 | -321,476 |
| Northern Trust Corp | 372,420 | +15,772 |
| Tudor Investment Corp ET AL | 356,697 | +41,470 |
Insiders
12 insiders reported holding 2,305,065 shares in total, about $81.8M at the last price.
| Holder | Shares |
|---|---|
| Rawlings DarrylDirector | 1,460,4911,435,340 held indirectly |
| Rubin Howard EDirector | 233,288 |
| Tooth MargaretCEO, Director | 184,952 |
| Low Murray BDirector | 154,534 |
| Weinrauch SteveEVP, North Am & Vet Strategy | 81,740 |
| Bearman AsherChief Legal Officer | 74,013 |
| Dreyer EmilyChief Revenue Officer | 35,627 |
| Gallagher John RChief Operating Officer | 32,880 |
| Wheeler SimonEVP, Trupanion International | 25,327 |
| Mcgibney BrennaChief Administration Officer | 14,437 |
Questions about TRUP
What does Trupanion, Inc. do?
Trupanion, Inc. is a company in the Health care sector, listed on NASDAQ as TRUP. Its shares trade on NASDAQ under the ticker TRUP.
What is Trupanion, Inc.'s net worth?
Trupanion, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $399.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Trupanion, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $26.6M on revenue of $1.6B, a net margin of 1.7%.
How much revenue does Trupanion, Inc. make?
Over the twelve months to September 30, 2026 Trupanion, Inc. reported revenue of $1.6B. That is 11.4% more than a year earlier.
When did Trupanion, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Trupanion, Inc.'s next earnings report?
Trupanion, Inc.'s next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare TRUP with
Follow TRUP
Get an email when Trupanion, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Trupanion, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.